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Abstract 
Canine leishmaniosis is a disease caused by Leishmania infantum, a vector‑borne parasite. Due to the zoonotic 
potential of canine leishmaniosis, infected dogs must be identified. Serological assays are the most common methods 
for the detection of L. infantum infection in dogs used in veterinary practice. The aim of the study was to assess the 
performance of a rapid immunochromatographic test (FASTest  LEISH®, MEGACOR Diagnostik) for the detection of 
specific antibodies to that of the L. infantum in dog sera. The results were simultaneously compared using a com‑
mercial brand of indirect immunofluorescence antibody test and an in‑house enzyme‑linked immunosorbent assay 
as references. Between the two reference tests, 232 serum samples out of 244, produced concordant results while 12 
exhibited discordant results. Of the 232 concordant samples, 121 were classified as L. infantum seropositive, and 111 
samples were previously classified as L. infantum seronegative by a combination of the reference assays. All samples 
that were seropositive by the reference tests were also positive according to the rapid test, and only one sample that 
was seronegative according to the two reference assays was positive according to the rapid test. Compared with the 
reference tests, the rapid test sensitivity was 100%, specificity was 99.1%, accuracy was 99.6%, Cohen’s kappa coef‑
ficient was 0.99, and the area under receiver operating characteristic curve was 0.995. The FASTest  LEISH® is a rapid, 
qualitative in‑clinic test with high sensitivity and specificity.
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Findings
Canine leishmaniosis is zoonotic disease caused by L. 
infantum, a vector-borne protozoan parasite transmit-
ted by phlebotomine sand flies under natural conditions. 
Clinical manifestations of infection may range from mild 
to absent to mild, several and even fatal disease. This 
variability is thought to be the result of cell-mediated 
immune response from the host which may be influenced 
by the genetic background of the dog [1]. Individual incu-
bation times range from a few months to several years 
[2]. The detection of L. infantum antibodies indicates 
existing or past infections. High antibody levels are often 
associated with a high parasitic load and disease [3]. 
Conversely, low antibody levels in clinically normal dogs 
with a negative result on molecular and/or parasitologi-
cal tests may indicate exposure or early stages of Leish-
mania infection [4]. Different confirmatory techniques 
were used and the diagnosis was based on the clinical 
manifestation and/or the laboratory abnormalities that 
were compatible with the disease as well as by the confir-
mation of L. infantum infection [5].
Serological assays, including enzyme-linked immu-
nosorbent assay (ELISA), indirect immunofluorescence 
antibody test (IFAT), and rapid tests, are the most com-
mon methods for the detection of infection in dogs [6]. 
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Rapid tests have been used as an important first step in 
diagnostic algorithms, enabling results to be obtained 
within a short time [7].
The present study evaluated the diagnostic perfor-
mances, including the sensitivity (probability of a posi-
tive test result among those having the target condition), 
specificity (probability of a negative test result among 
those without the target condition), accuracy (the abil-
ity of a test to differentiate the patient and healthy cases 
correctly) and area the receiver operating characteristic 
curve (measure of the usefulness of a test showing the 
relationship between sensitivity and specificity) of a rapid 
qualitative immunochromatographic in dogs with differ-
ent anti-Leishmania antibody levels and compared the 
results from a combination of two quantitative serologi-
cal tests, IFAT and ELISA, as reference tests.
Blood samples from 244 dogs of different breeds, ages, 
and genders that were naturally exposed to L. infantum 
infection were included in the study from May 2017 
to May 2018. These dogs presented at the Veterinary 
Teaching Hospital of the University of Zaragoza (Spain) 
for different diagnostic purposes, including the annual 
screening program for clinically healthy dogs, cases 
of suspected clinical leishmaniosis, the blood donor 
screening program and pre vaccination screening for 
L. infantum infection (Table  1). The serological status 
was recorded by a retrospective review of sample files 
through the laboratory database (Tables  2 and 3). Two 
aliquots of each obtained serum sample were stored 
at -20  °C until testing. Because samples were collected 
for the sole intention of determining a diagnosis, ethi-
cal approval was not needed. However, the owners were 
required to sign an informed consent.
The rapid test (FASTest  Leish®, MEGACOR Diagnos-
tik, Hörbranz, Austria) was performed following the 
Table 1 Details of dogs including purpose of diagnosis and signalment
Description Number of dogs (%)
Purpose of diagnosis Annual screening program for clinically healthy dogs 78 (32.0)
Cases of suspected clinical leishmaniosis 103 (42.2)
Blood donor screening program 23 (9.4)
Pre vaccination screening for L. infantum infection 40 (16.4)
Signalment
 Sex Male 115 (47.1)
Female 129 (52.9)
 Age 12 months of age 68 (27.9)
≥ 12 months of age and < 8 years of age 135 (55.3)
≥ 8 years of age 41 (16.8)
 Race Purebred 94 (38.5)
Mixed‑bred 150 (61.5)
Table 2 Frequency of  clinical signs in  diseased dogs 
(n = 121, with IFAT and ELISA result)
Lymphadenomegaly 98 (80.1)
Cutaneous involvement 86 (71.1)
Weight loss 67 (55.4)
Anorexia 54 (44.6)
Exercise intolerance 38 (31.4)
Ocular involvement 25 (20.7)
Pale mucous membranes 19 (15.7)
Fever 15 (12.4)
Lameness 11 (9.1)
Vomiting, diarrhea 7 (5.8)
Polyuria and polydipsia 4 (3.3)
Muscle atrophy 3 (2.5)
Splenomegaly 2 (1.7)
Table 3 Frequency of  hematologic and  biochemical 
alterations in diseased dogs (n = 121, with IFAT and ELISA 
result)
Hematological parameters
 Anemia 67 (55.4)
 Other hematological abnormalities
  Neutrophilia 17 (14.0)
  Lymphopenia 22 (18.2)
  Lymphocytosis 4 (3.3)
  Thrombocytopenia 10 (8.3)
Biochemical parameters
 Renal azotemia 9 (7.4)
 Hyperproteinemia with hypoalbuminemia and inverted 
albumin: globulin ratio
75 (62.0)
Urinalysis
 Proteinuria 43 (35.5)
 Decreased urine specific gravity 36 (29.8)
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instructions of the manufacturer. All tests were stored 
at room temperature and were performed as described 
in the instructions supplied with the test kit. This rapid 
test employs a combination of monoclonal antibodies 
conjugated with colloidal gold particles and recombi-
nant L. infantum antigens bound to the solid phase of 
a nitrocellulose membrane that detect anti-L. infantum 
antibodies in whole blood, plasma or serum from the 
dog. The antibodies against L. infantum present in the 
sample react in the conjugate pad with mobile mono-
clonal antibodies to form antibody complexes. These 
antibody complexes migrate along the nitrocellulose 
membrane and bind to fixed Leishmania spp. antigens, 
producing clear pink-purple colored test line. Particles 
that do not bind to the conjugate continue their course 
along the membrane and pass through the control line 
with membrane-fixed control antibodies. The control 
line shows that the sample and reagents have been 
properly applied and migrated through the device. The 
buffer diluent facilitates the migration and promotes 
the binding of antibodies to antigens. Samples with a 
clear test and control line are classified as positive, and 
samples that show a control line are classified as nega-
tive. Prior to the study, technicians were trained to per-
form and interpret results. All tests were read by two 
laboratory technicians after 15  min. If discrepancies 
arose between results, a third observer participated. 
The examiners were blinded to the results of the quan-
titative serological tests.
The commercial IFAT (MegaFLUO LEISH  test®, MEG-
ACOR Diagnostik, Hörbranz, Austria) was performed 
as described in the instructions supplied with the test 
kit. This commercial IFAT has been employed in other 
comparative studies of diagnostic tests [8]. All samples 
were examined by two different investigators. They were 
blinded to the results of the other serological tests. Sam-
ples negative at 1:100 were considered negative and the 
endpoint titer of positive samples was determined by 
preparing serial twofold dilutions of the serum starting 
from the cut-off value (1:100).
As a second quantitative serological reference method, 
an in-house ELISA by L. infantum was performed on all 
serum samples as previously described, with some modi-
fications [9]. The in-house ELISA test was performed by 
a different researcher who had no knowledge of the rapid 
test and IFAT results. The cut-off value was 30 ELISA 
unit (EU). Sera with an EU ≥ 200 were classified as high 
positive, with an EU ≥ 100 and < 200 as moderate posi-
tive, and with an EU > 30 and < 100 as low positive (Addi-
tional file 1).
Data obtained were checked for normal distribution 
using the Kolmogorov–Smirnov test (P > 0.05). A regres-
sion analysis between the two quantitative tests and 
Pearson´s correlation coefficients were calculated for all 
results that were concordant among the three serological 
tests. Statistical analyses were performed using IBM SPSS 
statistics software version 22 (SPSS Inc., Armonk, NY, 
USA). Because a single widely accepted reference stand-
ard for the diagnosis of L. infantum infection in dogs is 
not available, samples were classified based on results 
coinciding in both quantitative reference tests. Samples 
for which discordant results were obtained with the ref-
erence tests were not included in the study. Moreover, 
dogs that had previously been vaccinated with either of 
the two vaccines available in Spain for the prevention of 
canine leishmaniosis were also not included in this study.
Of the 244 sera analysed, 232 samples showed concord-
ant results for IFAT and the in-house ELISA. The remain-
ing 12 samples were considered discordant between 
reference tests, including 2 samples with a low positive 
result for the in-house ELISA but a negative result (anti-
body titer < 1:100) for the IFAT, as well as 10 samples with 
a positive result (antibody titer of 1:100) for the IFAT 
but negative result for the in-house ELISA. All discord-
ant samples between the two reference tests were clas-
sified as seronegative by the rapid test. Among the 232 
serum samples characterized, 121 samples were clas-
sified as seropositive for L. infantum infection and 111 
samples were classified as seronegative for L. infantum 
infection (Table 4). Serum samples with different serum 
Table 4 Comparison of the FASTest  LEISH® with IFAT and ELISA results for Leishmania spp. antibody detection
Number of samples IFAT and ELISA combination IFAT ELISA Total
Concordant results 
between reference tests
Discordant results 
between reference tests
Positive Negative Positive Negative
Positive Negative
FASTest  LEISH®
 Positive 121 1 0 121 1 121 1 122
 Negative 0 110 12 10 112 2 120 122
 Total 121 111 12 131 113 123 121 244
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anti-Leishmania spp. antibody levels were selected for 
the evaluation (Table 5). All serum samples classified as 
positive by both reference assays were also positive in the 
FASTest  LEISH®. Only one seronegative sample classi-
fied by the reference assays was discordant and showed 
a positive rapid test result. There were no additional 
freeze–thaw cycle or sample handing differences in test-
ing events between the three tests.
The rapid test achieved sensitivity of 100% (95% confi-
dence intervals (CI) 96.2–100%) and specificity of 99.1% 
(95% CI 94.4–100%), and the accuracy was 99.6% (95% 
CI 97.3–100%). The Cohen’s kappa coefficient between 
the rapid test and the combined reference assays for the 
detection of antibodies was 0.99. The area the receiver 
operating characteristic curve (AUC-ROC) obtained 
from the curve was 0.995 (95% CI 0.985–1.000) (Fig. 1). 
Agreement between the two observers in reading the 
rapid test was 100% and no invalid results were obtained. 
The regression line was statistically significant (P < 0.001) 
and Pearson´s correlation coefficient was r = 0.675.
Sensitivity and specificity are common parameters for 
evaluating diagnostic methods [10]. Depending on the 
purpose of the test, sensitivity or specificity should be 
prioritized. When a test is used to detect L. infantum 
infection in dogs with suspected clinical leishmaniosis, 
specificity and sensitivity must be high, but importantly, 
specificity must not be too low because a confirmatory 
test should be highly specific to avoid false positives. In 
contrast, high sensitivity is essential for identifying clini-
cally healthy infected dogs.
When a reliable gold standard is not available, at least 
two different tests should be performed [11]. In the pre-
sent study, sample classification was established based on 
combination of results from ELISA and IFAT, obtaining a 
better definition of the serological status. When different 
serological tests are used simultaneously, discrepancies 
may be observed, and the lack of consistency among tests 
may depend on their different performances. A possible 
explanation for these discrepancies may be the inherent 
differences in the two quantitative assays. Therefore, the 
differences between the diagnostic performances of the 
references tests may modify the accuracy of the rapid test 
analyzed.
Numerous rapid tests are available to detect antibod-
ies in dogs. However, these tests show high specificity 
and variable sensitivity [12]. Differences in diagnos-
tic results obtained between rapid tests are influenced 
by the serum panel, technology, type of antigen, test 
threshold and the different laboratory test considered 
as a reference assay (Table 6). Standardization and com-
parison of results between the evaluated test and other 
similar rapid tests from different studies is not possible 
due to differences in the parameters used to evaluate a 
test, such as sample size, definition of the clinical status 
of the dog involved in the study and the selected refer-
ence populations. Therefore, examinations of diagnos-
tic tests should follow the STARD guidelines (Standards 
for the Reporting of Diagnostic Accuracy Studies) to 
allow an adequate comparison between results.
Table 5 Number of positive samples and antibody levels (IFAT and ELISA)
IFAT 1:400 1:800 1:1600 1:3200 1:6400 > 1:6400
Number of samples 4 8 27 22 14 46
ELISA cutoff: 30 EU Low positive  
(> 30 and < 100 EU)
Moderate positive  
(≥ 100 and < 200 EU)
High positive 
(≥ 200 EU)
Number of samples 27 46 48
Fig. 1 AUC‑ROC curve analysis of the rapid test studied. The Area the 
receiver operating characteristic curve (AUC‑ROC) analysis combines 
sensitivity and specificity into one measurement, and the result is a 
single global measure of diagnostic effectiveness. Each point on the 
ROC curve represents a sensitivity/specificity pair corresponding to a 
particular decision threshold. The blue line represents the AUC‑ROC 
analysis of the FASTest  LEISH®, and the green line represents the 
reference line
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Sample inclusion can influence assessment measures 
with any test. Serum samples with high levels of anti-
Leishmania spp. antibodies are more easily detected by 
a test and contribute to higher diagnostic values [13]. 
Samples in the present study had different antibody lev-
els ranging from 42 to 372 EU, according to the in-house 
ELISA. Conversely, antibody titers detected by IFAT 
ranged from 1:400 to > 1:6400. The main differences 
between the ELISA and IFAT techniques are the type 
of antigen used and the technical method performed to 
obtain the results. In terms of interpreting the results, 
IFAT is subjective and depends on the operator´s expe-
rience, even when two different experienced observers 
examine the samples. This situation may explain the dis-
cordant results obtained.
A potential limitation of the present study was the lack 
of samples from dogs serologically reactive to other path-
ogens, particularly different Leishmania spp. or Trypano-
soma cruzi, which are both protozoa that belong to the 
Trypanosomatidae family and share various antigens that 
may produce cross-reactions [14, 15]. All serum samples 
were collected from dogs from the city of Zaragoza, a 
region in Spain where T. cruzi is not present and L. infan-
tum is the parasite responsible for canine leishmaniosis 
in Europe. Ideally, for a proper clinical sample characteri-
zation, the use of techniques of different nature is highly 
recommended. However, the objective of the study was 
to evaluated the ability of a rapid test to detect antibod-
ies. For this reason and to characterize the seropositive 
status of the samples, serological techniques are neces-
sary instead of other methods.
In conclusion, the use of FASTest  LEISH® as a screen-
ing test, may be particularly useful for identifying clini-
cally healthy, seropositive, infected dogs.
Additional fil
Additional file 1. Description of the in‑house indirect ELISA protocol for 
detection of anti‑Leishmania infantum antibodies.
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Table 6 Concordant results between  reference test and  results of  each reference test for  sensitivity and  specifici y 
of the FASTest  LEISH®
Reference test
IFAT and ELISA combination IFAT ELISA
FASTest  LEISH®
 Sensitivity (95% CI) 100% (96.2–100%) 92.4% (86.1–96.1%) 98.4% (93.7–99.8%)
 Specificity (95% CI) 99.1% (94.4–100%) 99.1% (94.5–100%) 99.2% (94.9–100%)
Number of samples included 232 244 244
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